Warning letter · FDA Warning Letters, Historical Archive

Northern Health Products: FDA Warning Letter (Dec 22, 2016)

Agency action: Dec 22, 2016Record ID: fda_warning_-e344758a074bacdc
View official source ↗

What happened

Original notice title

Northern Health Products 12/22/16

From the archived source record

Unapproved New Drugs FDA reviewed your website at the Internet address www.northernhealthproducts.com in September 2016 and determined that you take orders there for the products DCA Cancer Treatment Kit (Sodium Dichloroacetate and Thiamine Vitamin BlL ALA (Alpha Lipoic Acid), and N-A-C (N-Acetyl L- Cysteine). Thiamine is the food that DA uses so it's important to supplement your treatment with Thiamine to avoid Thiamine Deficiency and possible neuropathy (which is a result of Thiamine Deficiency, not a side-effect of DCA)." This product page directly links to this website: [see original source] • "DCA Cancer Information" • "Representatives from the University of Alberta (UA) claim that it is possible to use DCA as a cure for various forms of cancer. DCA was marked as relatively non-toxic and therefore action may be taken to test it on people with cancer." ALA Alpha Lipoic Acid • "Chelation treatment is the removal of toxic heavy metals such as lead and mercury using a product called DMSA." • "DMSA alone can NOT enter the brain to remove toxic heavy metals. SH groups react directly with many poisons, including herbicides, drugs (acetaminophen), environmental pollutants such as carbon tetrachloride, microorganisms including E. coli and aflatoxin, and against heavy metals. Indirectly, NAC helps with detoxification by producing optimal amounts of GSH for conjugation reactions, making harmful compounds less toxic." "NAC is approved as a drug for use to prevent liver damage from acetaminophen overdose." 4. Thus, these drugs are misbranded within the meaning of section 502(f)(1) of the Act, in that their labeling fails to bear adequate directions for use [21 U.S.C. § 352(f)(1)). The introduction of a misbranded drug into interstate commerce is a violation of section 301(a) of the Act [21 U.S.C. § 331(a)].

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Historical warning letter; closeout not established by annual index
Source checked
Jul 16, 2026
Record revision
edd1c1973cf3

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
DCA Cancer Treatment Kit; Pure DCA Cancer Treatment Supplement; DMSA Synergy; Chelation Therapy, DMSA, Heavy Metal Poisoning, Lead Poisoning, Mercury Poisoning; Pet DCA; DMSA Synergy as a dietary supplement; Gravol; DCA Cancer Treatment Kit (Sodium Dichloroacetate; Thiamine Vitamin BlL ALA (Alpha Lipoic Acid); and N-A-C (N-Acetyl L- Cysteine); DCA (sodium dichloroacetate)/ "Pet DCA
Company
Northern Health Products
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.